RNA seq

GENETIC2 trials

Sponsors

University Hospital, Montpellier, Australian & New Zealand Children's Haematology/Oncology Group

Conditions

Childhood Brain TumorChildhood CancerChildhood LeukemiaChildhood Solid TumorGenetic DiseaseMyopathyPhenotypic AbnormalityRefractory Cancer

Unknown Phase

Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy

RecruitingNCT03998540

University Hospital, MontpellierGenetic Disease, Myopathy, Phenotypic Abnormality

Start: 2019-12-05End: 2025-05-05Target: 50Updated: 2024-02-28

Precision Medicine for Every Child With Cancer

RecruitingNCT05504772

Australian & New Zealand Children's Haematology/Oncology GroupChildhood Brain Tumor, Childhood Cancer, Childhood Leukemia +3

Start: 2022-12-16End: 2030-07-31Target: 3500Updated: 2024-07-17

Related Papers

Navigating classical Hodgkin lymphoma in a patient with DIAPH1 deletion syndrome: Diagnostic and therapeutic challenges in a rare immuno-genetic context

Blood2025-11-03